Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Genotyping: one piece of the puzzle to personalize antiplatelet therapy.

Gurbel PA, Tantry US, Shuldiner AR, Kereiakes DJ.

J Am Coll Cardiol. 2010 Jul 6;56(2):112-6. doi: 10.1016/j.jacc.2010.04.008. Epub 2010 May 13.

2.

Pharmacogenomics of clopidogrel: evidence and perspectives.

Yin T, Miyata T.

Thromb Res. 2011 Oct;128(4):307-16. doi: 10.1016/j.thromres.2011.04.010. Epub 2011 May 18. Review.

PMID:
21592545
3.

Recent advances in the pharmacogenetics of clopidogrel.

Cuisset T, Morange PE, Alessi MC.

Hum Genet. 2012 May;131(5):653-64. doi: 10.1007/s00439-011-1130-6. Epub 2011 Dec 30. Review.

PMID:
22207144
4.

Impact of genetic and acquired alteration in cytochrome P450 system on pharmacologic and clinical response to clopidogrel.

Ma TK, Lam YY, Tan VP, Kiernan TJ, Yan BP.

Pharmacol Ther. 2010 Feb;125(2):249-59. doi: 10.1016/j.pharmthera.2009.10.008. Epub 2009 Nov 14. Review.

PMID:
19919843
5.

Personalized antiplatelet therapy: review of the latest clinical evidence.

Camilleri E, Jacquin L, Paganelli F, Bonello L.

Curr Cardiol Rep. 2011 Aug;13(4):296-302. doi: 10.1007/s11886-011-0194-1. Review.

PMID:
21594586
6.

Recent developments in clopidogrel pharmacology and their relation to clinical outcomes.

Gurbel PA, Antonino MJ, Tantry US.

Expert Opin Drug Metab Toxicol. 2009 Aug;5(8):989-1004. doi: 10.1517/17425250903107772. Review.

PMID:
19575629
7.

Antiplatelet therapy in the prevention of ischemic vascular events: literature review and evidence-based guidelines for drug selection.

Zusman RM, Chesebro JH, Comerota A, Hartmann JR, Massin EK, Raps E, Wolf PA.

Clin Cardiol. 1999 Sep;22(9):559-73. Review.

8.
10.

Optimizing platelet P2Y12 inhibition for patients undergoing PCI.

Steinhubl S, Roe MT.

Cardiovasc Drug Rev. 2007 Summer;25(2):188-203. Review. Erratum in: Cardiovasc Drug Rev. 2007 Autumn;25(3):299.

PMID:
17614940
11.

Antiplatelet drug response variability and the role of platelet function testing: a practical guide for interventional cardiologists.

Angiolillo DJ, Suryadevara S, Capranzano P, Zenni MZ, Guzman LA, Bass TA.

Catheter Cardiovasc Interv. 2009 Jan 1;73(1):1-14. doi: 10.1002/ccd.21782. Review.

PMID:
19089929
12.

Relation of CYP2C19 loss-of-function polymorphism to the occurrence of stent thrombosis.

Giusti B, Gori AM, Marcucci R, Abbate R.

Expert Opin Drug Metab Toxicol. 2010 Apr;6(4):393-407. doi: 10.1517/17425251003598878. Review.

PMID:
20163283
13.

Genetic variability in response to clopidogrel therapy and its clinical implications.

Yukhanyan L, Freynhofer MK, Siller-Matula J, Schrör K, Huber K.

Thromb Haemost. 2011 May;105 Suppl 1:S55-9. doi: 10.1160/THS10-11-0747. Epub 2011 Apr 11. Review.

PMID:
21479337
14.

Clopidogrel response variability, resistance, or both?

Wiviott SD.

Am J Cardiol. 2006 Nov 20;98(10A):18N-24N. Epub 2006 Sep 28. Review.

PMID:
17097413
15.

Resistance to clopidogrel: a review of the evidence.

Nguyen TA, Diodati JG, Pharand C.

J Am Coll Cardiol. 2005 Apr 19;45(8):1157-64. Review.

16.

Genetic causes of clopidogrel nonresponsiveness: which ones really count?

Momary KM, Dorsch MP, Bates ER.

Pharmacotherapy. 2010 Mar;30(3):265-74. doi: 10.1592/phco.30.3.265. Review.

PMID:
20180610
17.

Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives.

Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Alfonso F, Macaya C, Bass TA, Costa MA.

J Am Coll Cardiol. 2007 Apr 10;49(14):1505-16. Epub 2007 Mar 26. Review.

18.

Clopidogrel resistance.

Oqueli E, Hiscock M, Dick R.

Heart Lung Circ. 2007;16 Suppl 3:S17-28. Epub 2007 Jul 3. Review.

PMID:
17611155
19.

[Extent of platelet aggregation inhibition and clinical events: new evidence with prasugrel].

Abbate R, Crea F, De Servi S, Filippi E, Gensini GF, Golinos P, Savonitto S.

G Ital Cardiol (Rome). 2010 Feb;11(2):127-37. Review. Italian.

PMID:
20408476
20.

Clopidogrel and genetic testing: is it necessary for everyone?

Goswami S, Cheng-Lai A, Nawarskas J.

Cardiol Rev. 2012 Mar-Apr;20(2):96-100. doi: 10.1097/CRD.0b013e3182455744. Review.

PMID:
22293861
Items per page

Supplemental Content

Write to the Help Desk